Skip to content
★ Sign in to follow
张

张华东

Board Director
Director
奥翔药业
Total declarations
2
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (2 ops.)
€2.8M

Latest filing published 09 Dec 2022 for 奥翔药业, €571k.

Filing timeline

BuySale
张华东

Insider track record

Disclosed buys
0
Disclosed sells
2
Signal history

张华东: trading record in brief

张华东 is a declared insider of 奥翔药业 (board member), with filings sourced from SSE / SZSE (CSRC). Over a trading history stretching from 25 July 2022 to 9 December 2022, the count stands at 2 filings.

No open-market purchase appears, only 2 sales worth €2.8M.

Most recently, on 9 December 2022, the filings show an open-market sale worth €571k in 奥翔药业. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.

Companies and markets linked to 张华东

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ▼
    董事,高级管理人员Executives奥翔药业
    4M CNY9SSE
    160,000 shares20.5% of flowA股XSHGSSE:173000006118314180
  • ▼
    董事,高级管理人员Executives奥翔药业
    15M CNY27SSE
    320,000 shares79.5% of flowA股XSHGSSE:173000005711293540

2 of 2 declarations